Condition
BK Polyomavirus
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Early P 1 (1)
P 2 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07347769Not Yet Recruiting
Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals at Risk of Nephropathy
NCT06988072Not Yet RecruitingPrimary
Study of Anti-BKPyV Immune Responses in Kidney Transplant Patients With BKPyV Viremia
NCT04293042Early Phase 1RecruitingPrimary
Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients
NCT00104338Phase 2TerminatedPrimary
Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy
Showing all 4 trials